This is in contrast to a study by Sun et al., 2008 which showed that Rapamycin, an immunosuppressant agent which is recently used for cancer therapy, inhibited the expression of TLR4 on colon cancer cells (28). The gene discussed is TLR4; the disease is malignant colon neoplasm.